REQUEST A DEMO
Total
USD $0.00
Search more companies

Parexel International D.O.O. (Serbia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Parexel International D.O.O. Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Parexel International D.O.O. is based in Serbia, with the head office in Belgrade. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The company was established on July 07, 2008. It currently has a total number of 224 (2024) employees. From the latest financial highlights, Parexel International D.O.O. reported a net sales revenue drop of 5.08% in 2024. A growth of 23.73% was recorded in its total assets. The enterprise’s net profit margin decreased by 1.49% in 2024.

Headquarters
Takovska 46 A
Belgrade; Belgrade;

Contact Details: Purchase the Parexel International D.O.O. report to view the information.

Website: http://www.parexel.com

Basic Information
Total Employees:
Purchase the Parexel International D.O.O. report to view the information.
Registered Capital:
Purchase the Parexel International D.O.O. report to view the information.
Financial Auditors:
Purchase the Parexel International D.O.O. report to view the information.
Incorporation Date:
July 07, 2008
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Parexel International D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-5.08%
Total operating revenue
-5.08%
Operating profit (EBIT)
-36.31%
EBITDA
-32.61%
Net Profit (Loss) for the Period
-33.95%
Total assets
23.73%
Total equity
13.35%
Operating Profit Margin (ROS)
-2.34%
Net Profit Margin
-1.49%
Return on Equity (ROE)
-8.44%
Quick Ratio
-0.5%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?